The role of tacstd-2 level in hepatitis C patients (controlled clinical research)

scientific article published on 01 December 2019

The role of tacstd-2 level in hepatitis C patients (controlled clinical research) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1080/19932820.2019.1622363
P932PMC publication ID6567178
P698PubMed publication ID31146656

P50authorAylin Yetim ŞahinQ91733080
Fehmi AtesQ92411340
P2093author name stringMemduh Sahin
P2860cites workInfection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.Q52655967
TROP2 expression as prognostic marker for gastric carcinomaQ58217959
TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavityQ58217966
Human occludin is a hepatitis C virus entry factor required for infection of mouse cellsQ27490169
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryQ28131832
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002Q29619974
Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions.Q30539832
Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinomaQ31114927
Clinical significance of TROP2 expression in colorectal cancerQ33243832
Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway.Q34158118
Significance of EpCAM and TROP2 expression in non-small cell lung cancerQ35927755
Hepatocellular carcinoma development in cirrhosisQ36708154
High expression of TROP2 correlates with poor prognosis in pancreatic cancer.Q36944033
Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristicsQ37016384
Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfateQ38352468
TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cellsQ38803073
Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancersQ42816764
Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytesQ42999009
TROP2 expression and its correlation with tumor proliferation and angiogenesis in human gliomasQ45776265
Increased expression of Trop2 correlates with poor survival in extranodal NK/T cell lymphoma, nasal typeQ47694775
Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liverQ47835382
Monoclonal antibodies against occludin completely prevented hepatitis C virus infection in a mouse modelQ50043321
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue1
P304page(s)1622363
P577publication date2019-12-01
P1433published inLibyan journal of medicineQ26854001
P1476titleThe role of tacstd-2 level in hepatitis C patients (controlled clinical research)
P478volume14

Search more.